This is a quantitative proteomic study of the plasma of obese versus lean post-menopausal women collected over a two-year time span, to establish whether Lovaza (a collection of omega-3 fatty acids) would alter protein biomarkers involved in lipogenesis, inflammation, immunity and carcinogenesis in Obese versus Lean women.